# Short Term Reproducibility of Office White-coat Effect

Study · id `cardio:ct-nct06523062` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT06523062](<https://clinicaltrials.gov/study/NCT06523062>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT06523062

Browse, organ or system: Blood vessels  
Browse, condition area: High blood pressure  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 922 participants.

## Technical summary

Registry record NCT06523062. Non-randomized; single masking; primary purpose diagnostic. Start 2024-09-01 (anticipated); primary completion 2025-08-31 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; non-randomized; single masking; primary purpose diagnostic
- Phase: Not applicable
- Enrolled: 922 participants (planned count; ClinicalTrials.gov record NCT06523062, source copy `cardio:ctgov-nct06523062-2024-07-26`, retrieved 2026-10-26)
- Planned start: 2024-09-01 (anticipated) (ClinicalTrials.gov record NCT06523062, source copy `cardio:ctgov-nct06523062-2024-07-26`, retrieved 2026-10-26)
- Primary completion: 2025-08-31 (anticipated) (ClinicalTrials.gov record NCT06523062, source copy `cardio:ctgov-nct06523062-2024-07-26`, retrieved 2026-10-26)
- Completion: 2025-08-31 (anticipated) (ClinicalTrials.gov record NCT06523062, source copy `cardio:ctgov-nct06523062-2024-07-26`, retrieved 2026-10-26)
- Countries: Not reported
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct06523062-2024-07-26`, retrieved 2026-10-26)

## The registry's words

- Brief title: Short Term Reproducibility of Office White-coat Effect
- Acronym: REBBRE
- Condition: White Coat Hypertension
- Intervention (Device): blood pressure measurement
- Lead sponsor: University Hospital, Caen
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Hypertension (high blood pressure) (`core:hypertension`)
- Registry lists this organization as the lead sponsor: University Hospital, Caen (`cardio:org-university-hospital-caen`)

## Provenance

Content hash: ff90743f477e241fba23571b6dd14760e6309a94b37b066f9a303d93cb29fc99
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
